Immunization is one of the most effective, and cost-effective public health interventions in the world for preventing illness and death.
Hualan Genetic Engineering Co., Ltd. received the acceptance notice of the new drug clinical application for "Recombinant Anti-EGFR All-Human Monoclonal Antibody Injection" issued by the CFDA.
Vaccination of Anti-Rabies Vaccine is required, and Human Rabies Immunoglobulin may be required in serious cases. For any needs about Human Rabies Immunoglobulin or Anti-Rabies Vaccine, feel free to contact Hualan Bio!
Blood collection and supply institutions that can provide sufficient and safe blood and blood products to patients are key components of an effective health system.
The Conference of Research and Application of New Vaccines for Pandemic Influenza and Seasonal Influenza was held in Biomedical industrial Park of Central Plains Economic Zone.
CFDA approved the application for production registration of the Quadrivalent Influenza Vaccine produced by Hualan Biological Bacterin Co., Ltd.
Hualan Biological Bacterin Co., Ltd. obtained the approval document issued by the CFDA for the clinical trial of Adsorbed Hand-Foot-Mouth Disease ( EV71 ) Vaccine ( Vero Cells ), Inactivated.
Influenza Vaccine (Split, Virion), Quadrivalent developed by Hualan Bio has already applied for the production number and under review by Center for Drug Evaluation, CFDA currently.